COMPREHENSIVE EXAM QUESTIONS AND
CORRECT ANSWERS WITH DETAILED
RATIONALES
Section 1: Principles of Pharmacotherapy (Questions 1-30)
1. A nurse is reviewing a patient's medication list. Which of the following best
describes the term "pharmacodynamics"?
A) The process by which a drug is absorbed, distributed, metabolized, and
excreted.
B) The study of the biochemical and physiological effects of drugs and their
mechanisms of action.
C) The genetic variations that influence individual responses to drugs.
D) The study of how drugs are used to treat diseases.
Answer: B
Rationale: Pharmacodynamics is what the drug does to the body. It involves drug-
receptor interactions and the resulting physiological effects. Option A defines
pharmacokinetics. Option C defines pharmacogenomics. Option D is a broad
definition of pharmacotherapy.
2. A patient with renal impairment is prescribed a medication that is primarily
excreted by the kidneys. The nurse should anticipate which of the following
alterations in pharmacokinetics?
A) Decreased absorption
,B) Increased first-pass effect
C) Prolonged half-life
D) Increased distribution
Answer: C
Rationale: Impaired renal function leads to decreased clearance of drugs excreted
by the kidneys, which increases the drug's half-life and can lead to toxicity.
Absorption, first-pass effect, and distribution are less directly affected by renal
impairment.
3. Which of the following routes of administration bypasses the first-pass effect?
A) Oral
B) Rectal
C) Sublingual
D) Enteric-coated oral
Answer: C
Rationale: Sublingual administration allows the drug to be absorbed directly into
the systemic circulation under the tongue, bypassing the liver's first-pass
metabolism. Oral and rectal routes (partially) undergo first-pass metabolism.
4. A nurse is teaching a patient about their new prescription. Which of the
following statements indicates a need for further teaching regarding generic
drugs?
A) "The generic drug should have the same active ingredient as the brand name."
B) "The generic drug will always look exactly like the brand name drug."
,C) "The generic drug may have different inactive ingredients."
D) "The generic drug should be therapeutically equivalent."
Answer: B
Rationale: Generic drugs must have the same active ingredient, strength, dosage
form, and route of administration, and be therapeutically equivalent. However,
they can and often do look different due to different inactive ingredients
(excipients), colors, and shapes.
5. A patient is prescribed a drug with a narrow therapeutic index. The nurse
understands that this means:
A) The drug is highly effective with few side effects.
B) Small changes in dosage can lead to toxic or subtherapeutic effects.
C) The drug must be taken with food to be effective.
D) The drug is safe for use in pregnancy.
Answer: B
Rationale: A narrow therapeutic index (NTI) means there is a small difference
between the therapeutic dose and the toxic dose. These drugs require careful
monitoring, often through therapeutic drug monitoring (TDM) of blood levels.
6. Which of the following is a potential consequence of a drug being a potent
enzyme inducer?
A) Increased levels of other co-administered drugs.
B) Decreased metabolism of other co-administered drugs.
C) Decreased therapeutic effect of other co-administered drugs.
, D) Increased risk of toxicity from other co-administered drugs.
Answer: C
Rationale: Enzyme inducers increase the activity of metabolic enzymes (like
CYP450), leading to faster metabolism of other drugs. This can decrease the
concentration and therapeutic effect of those co-administered drugs.
7. A nurse is assessing a patient for potential drug allergies. Which of the
following is a type I, immediate hypersensitivity reaction?
A) Contact dermatitis
B) Anaphylaxis
C) Hemolytic anemia
D) Serum sickness
Answer: B
Rationale: Anaphylaxis is a severe, life-threatening type I (IgE-mediated)
hypersensitivity reaction. Contact dermatitis is a type IV delayed reaction.
Hemolytic anemia and serum sickness are type II and III reactions, respectively.
8. The term "prodrug" refers to a medication that:
A) Is active in its original form.
B) Must be metabolized by the body to become active.
C) Is administered via a topical route.
D) Has a very short half-life.
Answer: B